Breaking News, Collaborations & Alliances

BioDuro & Silicogenix Accelerates Novel Drug Discovery for Complex Diseases

The collaboration will create a path from concept to preclinical development of complex diseases in the Biopharmaceutical Industry.

By: Rachel Klemovitch

Assistant Editor

BioDuro, a global Contract Research, Development, and Manufacturing Organization, announced a partnership with Silicogenix (SGX), the pioneer of fit-for-purpose small molecule design technology that empowers polypharmacology and non-traditional drug development.  The collaboration combines BioDuro’s leading drug discovery platform with SGX’s frameworks to lower the cost and time barriers in developing complex therapies. SGX’s technology enables biopharma companies to initiate and test new ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters